Gilead API Process Tower

Graham was selected in 2016 to construct a new Active Pharmaceutical Ingredient (API) Process Tower, which will provide Gilead with additional manufacturing capability for investigational drugs for clinical research programs. This $119.8 million project stands four storeys tall with a total area of 48,462 square feet.

The structural steel frame building consists of four composite concrete and steel deck levels with a mechanical penthouse for equipment & roof access. The interior is composed primarily of specialized pharmaceutical equipment such as dryers, scrubbers, chillers, reactors, crystallizers and temperature control units, with various pumps & vessels. An extensive network of interconnecting Process Piping totaling 78,000 linear feet across 54 systems and over 1,600 valve and inline instruments. Electrically, there are 220,000 linear feet of power/instrumentation cable, 6 MCCs, 4 Transformers, and a Switchgear. Part of the project scope included the replacement of Gilead’s 25kV Primary Power network while coordinating outages of Gilead’s existing facilities to minimize the impact on their operations.

The project was successfully completed in November 2018 ahead of schedule and under budget. Graham supported the comprehensive commissioning and start-up process for the facility to help accelerate the timeline for full operations.